These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 21494079

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vogt-Koyanagi-Harada disease associated with interferon alpha-2b/ribavirin combination therapy.
    Sylvestre DL, Disston AR, Bui DP.
    J Viral Hepat; 2003 Nov; 10(6):467-70. PubMed ID: 14633182
    [Abstract] [Full Text] [Related]

  • 7. [Vogt-Koyanagi-Harada disease associated with interferon-alpha and ribavirin therapy for chronic hepatitis C infection].
    Chebil A, Kort F, Bouraoui R, Youssef NB, El Matri L.
    J Fr Ophtalmol; 2010 Mar; 33(3):185-8. PubMed ID: 20172621
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin.
    Demirturk N, Aykin N, Demirdal T, Cevik F.
    Eur J Dermatol; 2006 Mar; 16(5):579-80. PubMed ID: 17101483
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Summaries for patients. Re-treating patients with chronic hepatitis C who have not responded to peginterferon-alpha2b.
    Ann Intern Med; 2009 Apr 21; 150(8):I-34. PubMed ID: 19380849
    [No Abstract] [Full Text] [Related]

  • 15. Retinal thrombosis secondary to the combination therapy of pegylated interferon and ribavirin for chronic hepatitis C virus infection. A rare complication.
    Ortega-Ibarra FS, Remes-Troche JM.
    Rev Esp Enferm Dig; 2013 Apr 21; 105(5):291-2. PubMed ID: 23971660
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy.
    Jain S, Midha V, Sood A.
    Indian J Gastroenterol; 2011 Sep 21; 30(5):239-40. PubMed ID: 21986854
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [A case of sudden-onset hearing loss in a patient treated with peginterferon alpha-2b and ribavirin for chronic hepatitis C].
    Shin MK, Kim TH, Ju K, Ha CY, Min HJ, Jung WT, Lee OJ.
    Korean J Hepatol; 2009 Sep 21; 15(3):370-4. PubMed ID: 19783887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.